Wells Fargo downgraded NOV Inc. from Equal Weight to Underweight and set a new price target of $16.00 from $20.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/24/2025 | $22.00 | Sector Perform → Outperform | RBC Capital Mkts |
| 1/15/2025 | $25.00 → $18.00 | Outperform → In-line | Evercore ISI |
| 1/6/2025 | Buy → Neutral | Seaport Research Partners | |
| 12/19/2024 | $17.00 | Neutral | Piper Sandler |
| 11/11/2024 | $21.00 → $18.00 | Buy → Neutral | Citigroup |
| 10/28/2024 | $28.00 → $22.00 | Buy | TD Cowen |
| 9/25/2024 | $20.00 → $16.00 | Equal Weight → Underweight | Wells Fargo |
| 7/29/2024 | $27.00 → $28.00 | Buy | TD Cowen |
4 - NOV Inc. (0001021860) (Issuer)
4 - NOV Inc. (0001021860) (Issuer)
4 - NOV Inc. (0001021860) (Issuer)
SD - NOV Inc. (0001021860) (Filer)
8-K - NOV Inc. (0001021860) (Filer)
S-8 - NOV Inc. (0001021860) (Filer)